Lyme Borreliosis Clinical Trial
Official title:
Doxycycline in Therapy of Erythema Migrans - do the Accompanying Symptoms Influence the Outcome?
The investigators will compare the outcome of three groups of erythema migrans patients treated with doxycycline: a group without any accompanying symptoms, with mild symptoms and with severe symptoms that require lumbar puncture.
Patients with erythema migrans treated with doxycycline for two weeks will be followed-up for one year (at 2 weeks, 2, 6 and 12 months) clinically and also by filling in the questionnaire to assess the presence of certain symptoms. Also the control group of their friends or relatives without a history of Lyme borreliosis will be included. The presence of their (unspecific) symptoms will also be recorded by the questionnaire at the time of enrollment and at 6 and 12 months. ;
Observational Model: Case Control, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05641116 -
Effectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis.
|
N/A | |
| Active, not recruiting |
NCT04801420 -
Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population
|
Phase 2 | |
| Active, not recruiting |
NCT00576082 -
Borrelia Species in Cutaneous Lyme Borreliosis
|
||
| Completed |
NCT03873974 -
Performance Evaluation of the DualDur In Vitro Diagnostic System in the Diagnosis of Lyme Borreliosis
|
||
| Recruiting |
NCT05625100 -
Place of Intrathecal CXCL-13 in the Diagnosis of Lyme Neuroborreliosis
|
||
| Completed |
NCT03970733 -
Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis
|
Phase 2 | |
| Completed |
NCT03769194 -
Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.
|
Phase 2 |